Forian Inc
NASDAQ:FORA

Watchlist Manager
Forian Inc Logo
Forian Inc
NASDAQ:FORA
Watchlist
Price: 2.04 USD -3.77% Market Closed
Market Cap: 63.3m USD
Have any thoughts about
Forian Inc?
Write Note

Forian Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Forian Inc
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Forian Inc
NASDAQ:FORA
Short-Term Investments
$46.7m
CAGR 3-Years
56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Short-Term Investments
$4B
CAGR 3-Years
50%
CAGR 5-Years
46%
CAGR 10-Years
31%
Inspire Medical Systems Inc
NYSE:INSP
Short-Term Investments
$263.5m
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Short-Term Investments
$666.1m
CAGR 3-Years
106%
CAGR 5-Years
88%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Short-Term Investments
$21.2m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Forian Inc
Glance View

Market Cap
63.4m USD
Industry
Health Care

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.

FORA Intrinsic Value
2.04 USD
Fairly Valued
Intrinsic Value
Price

See Also

What is Forian Inc's Short-Term Investments?
Short-Term Investments
46.7m USD

Based on the financial report for Sep 30, 2024, Forian Inc's Short-Term Investments amounts to 46.7m USD.

What is Forian Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 3Y
56%

Over the last year, the Short-Term Investments growth was 7%. The average annual Short-Term Investments growth rates for Forian Inc have been 56% over the past three years .

Back to Top